Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Falck

Showing results (551-560 of 692) with videos related to

Pageof 70
Sort By:
Circulation Research|January 1, 1993
20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteriesY H Ma, D Gebremedhin, M L Schwartzman, et al.
Circulation Research|September 25, 2004
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathwayKasem Nithipatikom, Eric R Gross, Michael P Endsley, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand bindingWenqi Yang, Blythe B Holmes, V Raj Gopal, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 5, 2009
Enalapril treatment alters the contribution of epoxyeicosatrienoic acids but not gap junctions to endothelium-derived hyperpolarizing factor activity in mesenteric arteries of spontaneously hypertensive ratsAnthie Ellis, Kenichi Goto, Daniel J Chaston, et al.
Journal of Medicinal Chemistry|May 20, 2011
17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analoguesJohn R Falck, Gerd Wallukat, Narender Puli, et al.
Prostaglandins & Other Lipid Mediators|September 15, 2012
NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitriteBahar Tunctan, Ayse Nihal Sari, Meltem Kacan, et al.
Hypertension (Dallas, Tex. : 1979)|February 16, 2011
Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB KinaseCheng-Chia Wu, Jennifer Cheng, Frank Fan Zhang, et al.
Prostaglandins & Other Lipid Mediators|December 14, 2006
Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoidsMeetha Medhora, Anuradha Dhanasekaran, Stephanie K Gruenloh, et al.
The Journal of Biological Chemistry|June 24, 2004
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cellsHouli Jiang, John C McGiff, John Quilley, et al.
American Journal of Physiology. Renal Physiology|July 7, 2005
Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant ratsHui Huang, Yiqiang Zhou, Venugopal T Raju, et al.
Pageof 70

Showing results (551-560 of 692) with videos related to

Sort By:
Pageof 70
Circulation Research|January 1, 1993
20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteriesY H Ma, D Gebremedhin, M L Schwartzman, et al.
Circulation Research|September 25, 2004
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathwayKasem Nithipatikom, Eric R Gross, Michael P Endsley, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand bindingWenqi Yang, Blythe B Holmes, V Raj Gopal, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 5, 2009
Enalapril treatment alters the contribution of epoxyeicosatrienoic acids but not gap junctions to endothelium-derived hyperpolarizing factor activity in mesenteric arteries of spontaneously hypertensive ratsAnthie Ellis, Kenichi Goto, Daniel J Chaston, et al.
Journal of Medicinal Chemistry|May 20, 2011
17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analoguesJohn R Falck, Gerd Wallukat, Narender Puli, et al.
Prostaglandins & Other Lipid Mediators|September 15, 2012
NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitriteBahar Tunctan, Ayse Nihal Sari, Meltem Kacan, et al.
Hypertension (Dallas, Tex. : 1979)|February 16, 2011
Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB KinaseCheng-Chia Wu, Jennifer Cheng, Frank Fan Zhang, et al.
Prostaglandins & Other Lipid Mediators|December 14, 2006
Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoidsMeetha Medhora, Anuradha Dhanasekaran, Stephanie K Gruenloh, et al.
The Journal of Biological Chemistry|June 24, 2004
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cellsHouli Jiang, John C McGiff, John Quilley, et al.
American Journal of Physiology. Renal Physiology|July 7, 2005
Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant ratsHui Huang, Yiqiang Zhou, Venugopal T Raju, et al.
Pageof 70